Your session is about to expire
← Back to Search
Vaccine Education for COVID-19
Study Summary
This trial will test a new way of educating people about vaccines in order to get more people to get the vaccine, specifically in vulnerable communities in Louisiana.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have not completed your required COVID-19 vaccinations.You have received all doses of the COVID-19 vaccine, including the booster shot.You have allergies to any parts of the COVID-19 vaccines.You have reasons that make it unsafe for you to get a COVID-19 vaccine.
- Group 1: Participants Which Receive COVID-19 Vaccine Education at the Point of COVID-19 Testing
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are new participants still being sought to take part in this clinical experiment?
"Per the information listed on clinicaltrials.gov, this medical study is no longer in search of applicants. It was first published on January 1st 2022 and was last revised June 24th 2021; however, there are currently 1055 other trials actively searching for participants at this time."
Can individuals aged eighty-five and over participate in this clinical trial?
"The eligibility requirements of this trial indicate that the minimum age for participation is 18, while the maximum age applicable to participants is 99."
What type of participant is ideal for this research endeavor?
"This clinical trial is accepting participants with vaccine hesitancy who range from 18 to 99 years old. 375 individuals have been recruited so far, and the team plans to continue recruiting more."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger